Pluri (PLUR) Assets (2011 - 2025)
Pluri's (PLUR) quarterly Assets came in at $30.6 million in Q4 2025, down 0.86% year-over-year from $30.9 million in Q4 2024, and down 9.14% quarter-over-quarter from $33.7 million in Q3 2025.
Analysis
Pluri (PLUR) Assets (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Assets for 15 consecutive years, with $30.6 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Assets fell 0.86% year-over-year to $30.6 million in Q4 2025; TTM through Dec 2025 was $30.6 million, a 0.86% decrease from a year earlier, with the FY2025 full-year figure at $38.7 million, down 2.14% from the prior year.
- Assets was $30.6 million for Q4 2025 at Pluri, down from $33.7 million in the prior quarter.
- Over five years, Assets peaked at $93.5 million in Q2 2021 and troughed at $30.6 million in Q4 2025.
- A 5-year average of $54.0 million and a median of $47.7 million in 2023 frame the typical range for Assets.
- Across the five-year window, Assets surged 243.94% in 2021 and sank 35.3% in 2024, its largest moves.
- Over 5 years, Assets stood at $81.2 million in 2021, then retreated by 26.18% to $59.9 million in 2022, then sank by 30.64% to $41.6 million in 2023, then decreased by 25.75% to $30.9 million in 2024, then fell by 0.86% to $30.6 million in 2025.
- The last three Assets figures came in at $30.6 million (Q4 2025), $33.7 million (Q3 2025), and $38.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.50 Bn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.65 Bn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 915.53 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.75 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 985.10 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.39 Bn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 170.30 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 3.19 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 502.87 Mn |
| 10 | Pluri | 11.95 Mn | -536,034.04 | 86,000.00 | 30.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 30.60 Mn |
| Sep 30, 2025 | 33.67 Mn |
| Jun 30, 2025 | 38.68 Mn |
| Mar 31, 2025 | 37.41 Mn |
| Dec 31, 2024 | 30.86 Mn |
| Sep 30, 2024 | 35.44 Mn |
| Jun 30, 2024 | 39.53 Mn |
| Mar 31, 2024 | 36.39 Mn |
| Dec 31, 2023 | 41.56 Mn |
| Sep 30, 2023 | 44.54 Mn |
| Jun 30, 2023 | 50.80 Mn |
| Mar 31, 2023 | 56.24 Mn |
| Dec 31, 2022 | 59.93 Mn |
| Sep 30, 2022 | 59.75 Mn |
| Jun 30, 2022 | 68.07 Mn |
| Mar 31, 2022 | 79.13 Mn |
| Dec 31, 2021 | 81.18 Mn |
| Sep 30, 2021 | 83.75 Mn |
| Jun 30, 2021 | 93.54 Mn |
| Mar 31, 2021 | 79.17 Mn |